Selected Abstract
New Data Show Ceftobiprole as Effective as Combination Therapy in Treating Patients With Complicated Skin Infections, Including MRSA.
CHICAGO, Sept. 18 /PRNewswire/ -- Johnson & Johnson Pharmaceutical Research & Development, L.L.C., today announced that the investigational antibiotic ceftobiprole was as effective as commonly used combination therapy in treating patients with complicated skin infections caused by a broad ... September 18, 2007; PR Newswire
Read the full article with a free-trial membership at HighBeam Research
Related Articles 1.
Snyder, Robert G.
2.
Bulgarian figure skating champion sentenced to 2 1/2 years in prison
3.
1st Ld-Writethru: China curbs overseas trips on public expense
4.
Market exchange rates -- Jan. 6
5.
Shenzhen stock indices up -- Jan.5
6.
Hushen 300 index up -- Jan.5
7.
Rising stocks, dim export: economists post new year outlook for China's economy
8.
China's state companies expect 30 pct drop in 2008 profits
9.
Ship back from mission of tracking Shenzhou VII space flight
10.
eted with Chinese aid
|
